Novel Therapies for HDL Cholesterol
Share
Save
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.
Recommended
Details
Presenters
Overview
Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?